(Translation) UAC.CS/021/2018 November 14, 2018 Subject: Explanation of the operating results for the third quarter period ended September 30, 2018 To: President The Stock Exchange of Thailand
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
referral from the Stock Exchange of Thailand, the SEC probed into the case and found that on September 16, 2013, {A} had traded 130.12 million SSI shares by placing a total of 299 trading orders through
Management Discussion and Analysis, Q2/2019 Page1/4 Ref. IR62/008 9 August 2019 Subject: Management Discussion and Analysis, 2nd Quarter Ending 30 June 2019 Attention: President Stock Exchange of
SN.LK. 005/2019 February 21, 2019 Subject : Management Discussion and Analysis for the year ended 31 December 2018 Attn : The President The Stock Exchange of Thailand Indara Insurance Public Company
No. SN.LK 003/2018 February 20, 2018 The President Stock Exchange of Thailand Dear Sir: Indara Insurance Public Company Limited would like to report the company ‘s operating results and submit the
13 May 2019 Subject: Management Discussion and Analysis for the Quarter 1 Ending 31 March 2019 Attention: President Stock Exchange of Thailand Please find below the additional information supporting
Ref. No. 111/2562 August 14, 2019 SUBJECT : Management Discussion and Analysis ending June 30, 2019 ATTN : The President Stock Exchange of Thailand The Company would like to clarify the operation
31st March 2018 To : Managing Director Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at
November 8, 2018 SET-18-AC-003 Dear The President The Stock Exchange of Thailand Subject: Clarification of Result’s Operation for the three months ended 30 September 2018 According to the resolution